Literature DB >> 33801903

Resistance of Hypoxic Cells to Ionizing Radiation Is Mediated in Part via Hypoxia-Induced Quiescence.

Apostolos Menegakis1, Rob Klompmaker1, Claire Vennin2, Aina Arbusà1, Maartje Damen1, Bram van den Broek1,3, Daniel Zips4, Jacco van Rheenen2, Lenno Krenning1, René H Medema1.   

Abstract

Double strand breaks (DSBs) are highly toxic to a cell, a property that is exploited in radiation therapy. A critical component for the damage induction is cellular oxygen, making hypoxic tumor areas refractory to the efficacy of radiation treatment. During a fractionated radiation regimen, these hypoxic areas can be re-oxygenated. Nonetheless, hypoxia still constitutes a negative prognostic factor for the patient's outcome. We hypothesized that this might be attributed to specific hypoxia-induced cellular traits that are maintained upon reoxygenation. Here, we show that reoxygenation of hypoxic non-transformed RPE-1 cells fully restored induction of DSBs but the cells remain radioresistant as a consequence of hypoxia-induced quiescence. With the use of the cell cycle indicators (FUCCI), cell cycle-specific radiation sensitivity, the cell cycle phase duration with live cell imaging, and single cell tracing were assessed. We observed that RPE-1 cells experience a longer G1 phase under hypoxia and retain a large fraction of cells that are non-cycling. Expression of HPV oncoprotein E7 prevents hypoxia-induced quiescence and abolishes the radioprotective effect. In line with this, HPV-negative cancer cell lines retain radioresistance, while HPV-positive cancer cell lines are radiosensitized upon reoxygenation. Quiescence induction in hypoxia and its HPV-driven prevention was observed in 3D multicellular spheroids. Collectively, we identify a new hypoxia-dependent radioprotective phenotype due to hypoxia-induced quiescence that accounts for a global decrease in radiosensitivity that can be retained upon reoxygenation and is absent in cells expressing oncoprotein E7.

Entities:  

Keywords:  G1-arrest; HPV; hypoxia; quiescence; radiation resistance

Year:  2021        PMID: 33801903      PMCID: PMC7998378          DOI: 10.3390/cells10030610

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  80 in total

Review 1.  The same, only different - DNA damage checkpoints and their reversal throughout the cell cycle.

Authors:  Indra A Shaltiel; Lenno Krenning; Wytse Bruinsma; René H Medema
Journal:  J Cell Sci       Date:  2015-01-20       Impact factor: 5.285

2.  Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter.

Authors:  Yuhong Lu; Adrian Chu; Mitchell S Turker; Peter M Glazer
Journal:  Mol Cell Biol       Date:  2011-06-13       Impact factor: 4.272

3.  AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells.

Authors:  Tsutomu Shimura; Naoto Noma; Yui Sano; Yasushi Ochiai; Toshiyuki Oikawa; Manabu Fukumoto; Naoki Kunugita
Journal:  Radiother Oncol       Date:  2014-08-20       Impact factor: 6.280

4.  Transient activation of p53 in G2 phase is sufficient to induce senescence.

Authors:  Lenno Krenning; Femke M Feringa; Indra A Shaltiel; Jeroen van den Berg; René H Medema
Journal:  Mol Cell       Date:  2014-06-05       Impact factor: 17.970

5.  Patterns of Early p21 Dynamics Determine Proliferation-Senescence Cell Fate after Chemotherapy.

Authors:  Chien-Hsiang Hsu; Steven J Altschuler; Lani F Wu
Journal:  Cell       Date:  2019-06-13       Impact factor: 41.582

6.  MCM proteins are negative regulators of hypoxia-inducible factor 1.

Authors:  Maimon E Hubbi; Weibo Luo; Jin H Baek; Gregg L Semenza
Journal:  Mol Cell       Date:  2011-06-10       Impact factor: 17.970

7.  Effects of acute and chronic hypoxia on the radiosensitivity of gastric and esophageal cancer cells.

Authors:  Yukihiro Kato; Masakazu Yashiro; Yuhiko Fuyuhiro; Shinichiro Kashiwagi; Junko Matsuoka; Toshiki Hirakawa; Satoru Noda; Naoki Aomatsu; Tsuyoshi Hasegawa; Taro Matsuzaki; Tetsuji Sawada; Masaichi Ohira; Kosei Hirakawa
Journal:  Anticancer Res       Date:  2011-10       Impact factor: 2.480

8.  Hypoxia and radiation therapy: past history, ongoing research, and future promise.

Authors:  Sara Rockwell; Iwona T Dobrucki; Eugene Y Kim; S Tucker Marrison; Van Thuc Vu
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

Review 9.  Hypoxic radiosensitization: adored and ignored.

Authors:  Jens Overgaard
Journal:  J Clin Oncol       Date:  2007-09-10       Impact factor: 44.544

Review 10.  Transcriptional regulation by hypoxia inducible factors.

Authors:  Veronica L Dengler; Matthew Galbraith; Joaquín M Espinosa
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-10-07       Impact factor: 8.250

View more
  3 in total

Review 1.  Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers?

Authors:  Camil Ciprian Mireștean; Roxana Irina Iancu; Dragoș Petru Teodor Iancu
Journal:  Curr Oncol       Date:  2022-02-02       Impact factor: 3.677

2.  Indisulam synergizes with palbociclib to induce senescence through inhibition of CDK2 kinase activity.

Authors:  Ziva Pogacar; Jackie L Johnson; Lenno Krenning; Giulia De Conti; Fleur Jochems; Cor Lieftink; Arno Velds; Leyma Wardak; Kelvin Groot; Arnout Schepers; Liqin Wang; Ji-Ying Song; Marieke van de Ven; Olaf van Tellingen; Rene H Medema; Roderick L Beijersbergen; Rene Bernards; Rodrigo Leite de Oliveira
Journal:  PLoS One       Date:  2022-09-06       Impact factor: 3.752

3.  The Increase in the Drug Resistance of Acute Myeloid Leukemia THP-1 Cells in High-Density Cell Culture Is Associated with Inflammatory-like Activation and Anti-Apoptotic Bcl-2 Proteins.

Authors:  Margarita Kobyakova; Yana Lomovskaya; Anatoly Senotov; Alexey Lomovsky; Vladislav Minaychev; Irina Fadeeva; Daria Shtatnova; Kirill Krasnov; Alena Zvyagina; Irina Odinokova; Vladimir Akatov; Roman Fadeev
Journal:  Int J Mol Sci       Date:  2022-07-17       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.